Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
Decreased fibrinolytic capacity has been suggested to accelerate the process of arterial atherogenesis by facilitating thrombosis and fibrin deposition within developing atherosclerotic lesions. Type 1 plasminogen activator inhibitor (PAI-1) is the primary inhibitor of tissue-type plasminogen activa...
Na minha lista:
| 發表在: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
National Academy of Sciences
1992
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC49632/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1495992/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.89.15.6998 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|